Aline Frey
Actelion
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aline Frey as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:29 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT01112306 · ACT-293987 in Pulmonary Arterial HypertensionActelion · completed · Pulmonary Arterial Hypertension · study director
- Ph3NCT01106014 · Selexipag (ACT-293987) in Pulmonary Arterial HypertensionActelion · completed · Pulmonary Arterial Hypertension · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:29 UTC. The ranking covers the 200 most relevant of 45 PubMed records, and a shared surname and initials can bring in a namesake. All 45 on PubMed
- Selexipag for the Treatment of Pulmonary Arterial Hypertension.N Engl J Med · 2015821 citationsRCR 31.7
- 678 citationsRCR 30.5
- 538 citationsRCR 17.5
- 519 citationsRCR 18.1
- 293 citationsRCR 7.5
- 279 citationsRCR 7.3
- Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling.Stroke · 2012276 citationsRCR 10.4
- Slow breathing increases arterial baroreflex sensitivity in patients with chronic heart failure.Circulation · 2002187 citationsRCR 5.8
- Effect of breathing rate on oxygen saturation and exercise performance in chronic heart failure.Lancet · 1998179 citationsRCR 6.5
- Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.Bone Marrow Transplant · 1998177 citationsRCR 4.5